Viewing Study NCT02117934

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2026-03-06 @ 7:47 AM
Study NCT ID: NCT02117934
Status: COMPLETED
Last Update Posted: 2019-03-20
First Post: 2014-04-15
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
Sponsor: Dynavax Technologies Corporation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HBV vaccine View
None HEPLISAV-B View
None Hepatitis B vaccine View
None Hepatitis B View
None Hepatitis View
None Hepatitis B virus (HBV) View
None Prevention and Control View
None Healthy View
None Healthy volunteers View